The agreement will make insulin and obesity treatments more affordable through federal programmes and direct-to-patient ...

The company's semaglutide-based weight-loss drugs will be made available in the US through Medicare and Medicaid ...

2. Use shared criteria to guide portfolio choices A transparent, data-driven, decision-making framework helps global and ...

The drug candidate has been given breakthrough and priority medicines designations from the FDA and EMA respectively ...

Under the terms of the latest agreement, CDR-Life could receive up to up to $570m in total payments. This includes ...

Branded or unbranded? In clinical marketing, this choice shapes how your message lands. Learn how to pick the right strategy ...

Platelet functionality analysis could pave the way to improving drug asset selection and de-risking clinical trials ...

But there is also an important R we need, to help maintain our well-being through these turbulent times, and that’s ...

Today, the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) proudly marks European Laboratory Day, ...

Acquisition will add in-house continuous manufacturing expertise and expand Sandoz’s biosimilar production capacity ...

Novo Nordisk has reported strong financial results for the first nine months of 2025, with sales rising by 12% and operating ...

To open up more clinical paths for patients, HCPs need simpler search tools, better access to information and integrated ...